Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008:59:443-53.
doi: 10.1146/annurev.med.59.062606.122232.

Adaptive treatment strategies in chronic disease

Philip W Lavori  1 , Ree Dawson
Affiliations
Review

Adaptive treatment strategies in chronic disease

Philip W Lavori et al. Annu Rev Med. 2008.

Abstract

An adaptive treatment strategy (ATS) is a rule for adapting a treatment plan to a patient's history of previous treatments and the response to those treatments. The ongoing management of chronic disease defines an ATS, which may be implicit and hidden or explicit and well-specified. The ATS is characterized by the use of intermediate, early markers of response to dynamically alter treatment decisions, in order to achieve a favorable ultimate outcome. We illustrate the ATS concept and describe how the effect of initial treatment decisions depends on the performance of subsequent decisions at later stages. We show how to compare two or more ATSs, or to determine an optimal ATS, using a sequential multiple assignment randomized (SMAR) trial. Designers of clinical trials might find the ATS concept useful in improving the efficiency and ecological relevance of clinical trials.

PubMed Disclaimer

References

    1. Lavori PW, Dawson R, Rush AJ. Flexible treatment strategies in chronic disease: Clinical and research implications. Biol Psychiatry. 2000;48:605–614. - PubMed
    1. Lavori PW, Dawson R. Developing and comparing treatment strategies: An annotated portfolio of designs. Psychopharm Bull. 1998;34(1):13–18. - PubMed
    1. Lavori PW, Dawson R. A design for testing clinical strategies: biased individually tailored within-subject randomization. J Royal Statist Soc Series A. 2000;163:29–38.
    1. Murphy SA. An experimental design for the development of adaptive treatment strategies. Stat Med. 2005;24:1455–1481. - PubMed
    1. Habermann TM, Weller EA, Morrison VA, Gascoyne RD, et al. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol. 2006;24:3121–3127. - PubMed

Publication types